Mirae Asset Global ETFs Holdings’s iRadimed IRMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Buy	3,910 +80	+2%	+$7.29K	﹤0.01%	2157
2026 Q1	$369K	Buy	3,830 +69	+2%	+$6.9K	﹤0.01%	2045
2025 Q4	$366K	Buy	3,761 +36	+1%	+$3.09K	﹤0.01%	2045
2025 Q3	$265K	Sell	3,725 -734	-16%	-$48.9K	﹤0.01%	2173
2025 Q2	$267K	Sell	4,459 -352	-7%	-$19.3K	﹤0.01%	2132
2025 Q1	$252K	Buy	4,811 +234	+5%	+$13.1K	﹤0.01%	2197
2024 Q4	$252K	Buy	4,577 +204	+5%	+$10.7K	﹤0.01%	2263
2024 Q3	$220K	Buy	4,373 +1,119	+34%	+$51.6K	﹤0.01%	2331
2024 Q2	$143K	Buy	+3,254	New	+$138K	﹤0.01%	2421

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IRMD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its iRadimed (IRMD) stake by 2.1% in Q2 2026, buying an estimated $7.29K and bringing the position to 3,910 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Mirae Asset Global ETFs Holdings first reported a position in IRMD in Q2 2024 and has held it in 9 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Mirae Asset Global ETFs Holdings held 3,910 shares of iRadimed worth $374K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 80 iRadimed shares in Q2 2026, an estimated $7.29K.
iRadimed made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2157 holding.
Mirae Asset Global ETFs Holdings first reported a position in iRadimed in Q2 2024 and has held it in 9 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.